Introduction
Switzerland, United Kingdom, Ireland Czechia, Slovakia, 348 12 Over one million patients are currently maintained on The possible influence of different treatment-related Total 2836 100
factors on the outcome of dialysis was the topic for the Dialysis Opinion survey in 1998. In connection with the two major nephrology congresses during that year, the ERA-EDTA Congress held in Rimini in
The dose of haemodialysis
June, and the Annual Meeting of the ASN held in Philadelphia in October, a questionnaire was distribQuestion: The dose of haemodialysis (HD) is usually uted to the participants asking for their opinion on measured in terms of Kt/V for urea. A minimum dose how the outcome of dialysis is affected by dose, time, necessary to achieve adequate treatment is recommembrane, frequency, and self-care. The opinion poll mended by the DOQI guidelines (spKt/V=1.2). If the collected 4567 responses in total, with 2836 coming dose of dialysis could be increased by 50% above the from doctors ( Table 1) . The result was presented at DOQI minimum level for all HD patients, which the Dialysis Opinion Symposium held during the impact do you think this would have on the global ERA-EDTA Congress in Madrid, where a group of outcome? leading nephrologists chaired by E. Ritz gave their Answer: An overwhelming majority of dialysis profespersonal comments to the issues covered by the survey sionals, over 90% of the responding nephrologists, and discussed the responses from their colleagues expressed the opinion that a major increase of the dose around the world.
of HD would have a positive effect on patient survival ( Figure 1a) , with the majority believing that this effect would be significant. This opinion was shared by a significant effect was especially strong (>60%) among function of morbidity in relation to dose was presented. German, French and Scandinavian nephrologists. It showed that dialysis morbidity changed dramatically at Kt/V=0.8. At lower dialysis doses morbidity was very high, while at dialysis doses above this value Comments by N. Lameire morbidity was low and constant. The conclusion was that as long as the dose is above a critical value, which was later set at Kt/V=1.0, there should be no need to The major scientific effort to elucidate the impact of increase it further. The data from the NCDS was later the dialysis dose on outcome is still the National reanalysed by Keshaviah [2] , who could show that Cooperative Dialysis Study (NCDS), although now there is indeed a continuous relationship between mor-20 years old. When the result of this study was analysed bidity and dose, which indicates that increasing the by Gotch and Sargent [1], a quantification of the dialysis dose was introduced and the well-known step dose should continue to lead to improvements in morbidity. Further support for this concept has come directly to facts. If we look at the evolution of dialysis session duration, the gold standard of 3×10 h/week from the USRDS, reporting similar improvements in with a 1-m2 Kiil dialyser had been already set during mortality with increased dose of dialysis, expressed as the first decade of HD. come and dose expressed as Kt/V. A consequence of transformed the doses from single-pool to double-pool this was that the session time was further reduced to Kt/V, i.e. equilibrated Kt/V (eKt/V ), using patient 3×3 h. However, in 1989 the Dallas conference showed data in two large US databases, they found that the that the mortality of dialysis patients in the US was relative risk of mortality showed a steep decline when increasing and that this was developing in parallel with the dialysis dose was increased up to eKt/V=1.05 [4] .
decreases in time and dose [6 ] . Since then the dose as Above this dose there was no further improvement in well as the time have increased and mortality has come mortality. Their conclusion was that as long as a down in the US [3] . thrice-weekly dose of eKt/V=1.0-1.1 is delivered,
Today we see renewed interest in longer and more there is no further benefit to be gained by increasing frequent sessions. The goal of HD for the coming the dose. millennium is optimal dialysis and to achieve this we However, there is evidence from Europe that survival need the combination of at least five factors: sufficient can be significantly improved when a large dose of removal of (i) small and (ii) middle molecules, (iii) dialysis is delivered. The clinic in Tassin, France, has adequate nutrition for proteins and calories, (iv) satisthe best-documented survival of their HD patients in factory extracellular volume ( ECV ) control, and (v) the world and their dialysis is characterized by a high blood pressure (BP) control. Each of these conditions Kt/V, but also by long treatment times [5] . As shown is mandatory, and if only one of them fails to be by Gotch et al. in an interesting analysis, the wide fulfilled, a poor outcome results. The common denomdistribution of Kt/V values around the mean for the inator for all of them is TIME. Only one of them, Tassin patients makes it difficult to relate the impact small molecule removal, can be achieved within a short on survival to the Kt/V [4] . This indicates the influence treatment time. The next two, middle molecule dose of another factor, perhaps more homogeneously and good nutrition, require more time, and the last applied in Tassin, namely the treatment time.
two, ECV and BP control, are the most timeMy personal response is therefore that if the dose is dependent. The result of reduced treatment times is increased without manipulating the time, there is little that today a majority of HD patients are hypertensive evidence that this could have an effect on mortality. and die of uncontrolled cardiovascular disease. At the Still, I am not surprised by the result of the opinion same time, mortality from these same diseases is poll, as most people have the general feeling that more reduced by 30% in the general population according is better. Finally, I can only emphasize that we need to the Framingham study [7] . In addition to providing studies to find where the limits are.
the necessary dose, nutrition, and blood pressure control, an increased treatment time has the benefit of reducing the unphysiological and the intradialytic mor-
The treatment time bidity and increasing the operational safety of the HD delivery. Altogether a longer or more frequent dialysis Question: The treatment time in HD is sometimes is more adapted to the increasingly fragile population claimed to be even more important than the dose. If we have to treat. it were possible to extend the treatment time by 50% My response to the question is therefore that if for all HD patients, which impact do you think this everybody could increase the treatment time, it would would have on the global outcome?
have a significant and an important positive effect on Answer: Increasing the treatment time would lead to outcome. I am obviously pleased to see that the increased survival according to an overwhelming majority of nephrologists consider time and dose to be majority of respondents in the survey, close to 90% the most important parameters. However, dose in this (Figure 1b) . Over 50% of the responding nephrologists particular question refers to Kt/V, which is mainly felt that this effect would be significant. The significance small solute removal, and for me the removal of of extending the time was most strongly expressed by phosphate and larger solutes is also important. This is Scandinavian and German nephrologists (>70%), mainly affected by increased time and therefore treatwhile in North America it was chosen by only 48%. ment time remains the most important factor.
Comments by B. Charra High-flux, biocompatible membranes
Having only 5 min to show that longer dialysis dura-Question: High-flux, biocompatible dialysis membranes are increasingly used. Still, only about one-third of all tion is better leaves no time for theory, so let me go HD patients world-wide are currently dialysed with
In conclusion, the use of semi-synthetic and synthetic membranes and high flux seem to reduce morbidity these membranes. If all dialysers were of the high-flux, biocompatible type and no other parameter of the and mortality in dialysis patients. However, the real impact of the biological superiority of synthetic memtreatment were changed, which impact do you think this would have on the global outcome?
branes on clinical status and the clinical importance of high-flux treatments still need to be completely clarified Answer: In total 75% of the respondents said that the use of high-flux, biocompatible membranes would have [10] . Indeed, the results of published prospective, randomized, controlled trials are conflicting, while on the a positive impact on survival, but the majority felt that it would only be a trend ( Figure 1c) .
other hand, in several non-randomized retrospective studies, it is difficult to ascribe the positive effects entirely to the different modalities, because of the many
Comments by F. Locatelli
confounders. Only the results of prospective trials with a long follow-up will better clarify the effect of different treatment modalities on the morbidity and mortality In addition to the dialysis dose, the choice of dialysis membrane is increasingly considered to be essential for of patients on renal replacement therapy [14, 15] . improving morbidity and mortality of haemodialysis patients, because the use of so-called bioincompatible membranes can lead to a large number of side-effects. Daily dialysis However, the biocompatibility of dialysis also depends on factors other than the membrane, such as the Question: The intermittency of HD, as it is organized dialysate, dialyser geometry, the distribution of blood today, is often cited as the cause of many dialysisin the dialyser, and the sterilizing agent and materials related problems. If daily dialysis (6 days per week) used in reprocessing. Highly permeable synthetic mem-were practised instead for all HD patients, with no branes differ from conventional cellulose membranes change in the total treatment time per week, which insofar as they have minimal inflammatory-type con-impact do you think this would have on the global tact reactions with blood, and because their large pores outcome? allow better convective transport, leading to the Answer: Distributing the weekly treatment time of HD removal of medium-sized and large molecules. Epide-over 6 rather than 3 days is believed to influence miological studies suggest that semi-synthetic and syn-survival positively (Figure 1d ). One-third of the thetic membranes and/or high-flux may reduce morbid-respondents said such an effect would be significant, ity and mortality in dialysis patients [8] . The results while another one-third felt it would be a trend. of a historical, prospective study performed using data from the USRDS showed that the relative risk of mortality in patients dialysed with modified cellulose
Comments by M. Kooistra
or synthetic membranes was at least 20% less than that of patients treated with unsubstituted cellulose membranes [9] . However, since most synthetic and (to a Most nephrologists agree that maintenance of homeostasis is a prerequisite for health. A continuous much lesser extent) modified cellulose membranes have a higher clearance of medium-sized molecules, this and adequate renal function is important for the regulation of a constant and normal biochemical comcould also contribute to the result.
Several groups have found significantly reduced risks position and volume of the body fluids. However, the same physicians, while treating HD patients, seem to of mortality when dialysis with high-flux membranes was compared with standard HD (reviewed in [10] ). be satisfied with a very unphysiological therapy that combines inadequacy with infrequency. Many HD However, Locatelli et al. did not find any difference in mortality and morbidity among 380 patients random-patients are overhydrated and dehydrated three times a week, hypertensive and hypotensive three times a ized to low-flux haemodialysis with biocompatible and bioincompatible membranes and high-flux haemodia-week, acidotic and alkalotic three times a week, and hyperkalaemic and hypokalaemic three times a week. lysis and haemodiafiltration [11] . This trial, however, was not designed to evaluate the possible difference in In fact, most HD patients are still exposed to the so-called 'unphysiology' of dialysis, described almost morbidity and mortality (also considering that the number of events was rather small ), and the observa-25 years ago, even when their dialysis is referred to as adequate [16 ] . tion period of 24 months did not permit any significant evaluation of a possible difference in long-term morbidTheoretically, when a daily dialysis schedule is compared to a conventional three times per week schedule, ity and mortality. On the other hand, in a study of 6440 patients treated in Lombardy between 1983 and both resulting in a similar weekly Kt/V, two major differences can be observed. The urea concentration 1995 the relative risk for mortality was found to be lower when convective treatments were used (−10%) has lower peaks and is reduced less during daily dialysis, resulting in fewer fluctuations and perhaps although this difference was not statistically significant [12] . Significantly reduced morbidity, expressed as less morbidity. The body water content is affected similarly, which may be even more important for carpal-tunnel syndrome surgery, has also been reported from some of these studies [12, 13] .
clinical practice. The increased frequency results in less fluctuation between overhydration and dehydration, lysis, with equal numbers on HD and PD, which impact do you think this would have on the global and greater haemodynamic stability.
It has been shown mathematically that for a given outcome? Answer: Over half of the respondents expressed the time-average concentration of urea, a lower dialysis dose is required when frequency is higher [17] . In opinion that extended use of home/self-care dialysis would improve the survival among dialysis patients, other words: a given weekly Kt/V is worth more when delivered at a higher frequency. This means that the although this would be seen mainly as a trend ( Figure 1e ). The largest support for home/self-care was weekly Kt/V of an intermittent treatment cannot be compared with a similar Kt/V delivered in a continuous found among the respondents from North America, where >70% said it would improve survival. treatment, which is obvious for everybody working with CAPD patients. When the 'equivalent renal clearance' of different treatment schedules is calculated and Comments by M. Kessler compared, it shows that increasing the number of dialysis sessions per week is often more effective than increasing the dialysis dose of a session applied three An adequate answer to this question requires an adequate definition of home and self-care dialysis. times weekly [18] .
What about the clinical relevance of more frequent Home HD is performed at home after several weeks of training for the patient and the assistant, usually dialysis? Many workers during the last decades showed a marked improvement of several clinical items, includ-the spouse. True self-care HD is performed near the home in a non-medical unit, a home substitute. Patients ing erythropoiesis, metabolic control, volume and blood pressure regulation, cardiac function, brain func-are trained similarly to home HD and have a personal machine. A nurse is present throughout the session in tion, working capacity, and quality of life when patients were treated on a short daily basis [19] . Unfortunately, order to help the patients if necessary. This modality is quite different from the so-called self-care HD in these studies were not controlled and when switching to a daily schedule the dialysis dose was often France, which is a disguised form of in-centre HD, justified by the lack of hospital HD facilities. increased. In the special form of daily dialysis referred to as nocturnal dialysis long dialysis sessions are comThere are relatively few data comparing clinical outcome of home/self-care HD with hospital HD and bined with increased frequency and the result is very high Kt/V values and outstanding metabolic and PD, and the reports include patients dialysed prior to 1990. Using the Cox proportional hazards model haemodynamic control [20] .
To investigate the clinical significance of the mathem-Woods et al. [22] demonstrated that the relative risk of death in 70 home HD patients compared to 3103 atical idea that a given weekly Kt/V is worth more when delivered on a more frequent basis, we performed centre HD patients in the US was 0.58, when adjusted for comorbidity, age, sex, race, and diabetes. Prescribed daily (six times per week) home HD without increasing total weekly Kt/V [21]. This resulted in some improve-dialysis dose and serum albumin were similar in both groups of HD patients. Long-term survival in home/ ment of metabolic control, a marked improvement of blood pressure and haemodynamic control, and a self-care HD is not unusual if patients do not undergo renal transplantation, and the survival rate in 417 better quality of life, all achieved at a cost that is similar to in-hospital HD thrice weekly. patients treated with home and self-care HD was 77% at 10 years and 45% at 20 years [23] . In a study of In conclusion, I feel that both a theoretical basis and clinical evidence are available for the statement 859 patients undergoing dialysis or transplantation, Evans et al. [24] showed that among the patients that daily HD improves the outcome of the treatment. Increasing dialysis frequency is a powerful tool that treated by dialysis, those undergoing treatment at home had the highest quality of life. All differences were can be used when the dialysis treatment is insufficient. It is reassuring to see that so many colleagues appreci-found to persist even after the patient case mix had been controlled statistically. A recent study also ate the importance of increasing the frequency of dialysis, although so few have had the possibility to showed that patients trained for self-care HD experienced better subjective quality of life than in-centre practise it yet. Personally, I would say that combining an increase of time, dose, and frequency with a biocom-patients [25] .
In conclusion, haemodialysis at home or in self-care patible membrane and doing all this at home would give the best result. That is what is practised in the HD units with training provides better survival and quality of life than in-centre HD, and probably than nocturnal dialysis programme in Toronto [20] .
long-term PD, even after adjustment for patient characteristics and comorbidity. These results are supported
Home/self-care dialysis
only by epidemiological studies which show associations but which cannot prove causation. Explanations for the difference are probably multiple. There is Question: Home/self-care dialysis is known to result in better outcomes than dialysis at an institution, but the undoubtedly a substantial selection of home/self-care HD patients. Comorbidity was found to be as frequent reasons for this are not clear, because patient selection makes valid comparisons difficult. If 50% of all new in home HD compared with hospital HD but severity of comorbid conditions might be lower. Patients at dialysis patients were trained for home/self-care dia-home or in self-care units with training have personal min/week, with a weekly filtration capacity for small molecular weight substances of about 1200 litres. machines and finally independence. Better motivation could lead to more patient involvement.
Compare this to the currently available extracorporeal dialysis systems which are exclusively filtration devices, I find it interesting that the majority of the respondents say that time and dose are the most important deprived of any reabsorptive or endocrine regulatory function, operating for 700-1500 min/week with a parameters for improved outcome. However, under present conditions the only realistic way to increase small-molecule filtration capacity no greater than 150-200 l/week, which is at best 15% of that of the the time and the dose is to perform dialysis at home. So we should view increased use of home/self-care healthy human kidney. Indeed, the true miracle is that these very primitive devices are able to provide several dialysis as an important component for improved outcome.
decades of survival time for the patients.
If it can be postulated that optimal extracorporeal renal replacement therapies should provide depurative
What is most important?
functions closest to that achieved by the human kidney, which of the currently available modes of therapy are best approaching this goal? Haemodiafiltration, by Question: Of the five possible changes discussed above, regarding the dose, time, membrane, frequency, and combining diffusive and convective mechanisms of fluid and solute removal, simultaneously enhances the patient involvement, which single factor do you think could have the greatest positive impact on the global dialysis dose, enlarges the spectrum of removed uraemic toxins, and is performed with the currently outcome? Answer: One-third of the doctors responding to the best biocompatible components. In spite of these advantages, the patient mortality was not found to be survey chose an increased dose of dialysis as the most important factor for improved outcome (Figure 1f ) . significantly different in a study where one form of haemodiafiltration was compared with conventional Extending the time was considered slightly less important. The importance of time was especially emphasized dialysis methods [11] . Long nightly haemodialysis is another approach for optimizing the overall performby the Germans, while dose was strongly preferred by nephrologists from North America.
ances of an extracorporeal dialysis system insofar as it combines the delivery of a high dialysis dose with a prolonged dialysis time and the benefits from a home-
